Robert Camerlinck serves as Executive at Cano Health, Inc., where they oversee executive responsibilities. Since joining the company, Robert Camerlinck has executed 6 insider transactions totaling $23.6K, demonstrating a bearish approach to their equity position. Their most recent transaction on Aug 11, 2023 involved selling 30,646 shares valued at $23.6K.
Robert Camerlinck currently holds 26,958,642 shares of Cano Health, Inc. (CANO), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Robert Camerlinck has been a net seller of CANO stock. They have purchased $0 and sold $23.6K worth of shares.
Robert Camerlinck's most recent insider trade was on Aug 11, 2023, when they sold 30,646 shares at $0.77 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Apr 5, 2023 | CANO | $0 | Other | 2,836,540 | $N/A | Discretionary |
| Mar 31, 2023 | CANO | $0 | Award | 70,486 | $N/A | Discretionary |
| Sep 1, 2022 | CANO | $0 | Other | 25,386 | $N/A | Discretionary |
| Aug 10, 2022 | CANO | $0 | Award | 250,000 | $N/A | Discretionary |